Poehling Capital Management, Inc. Amgen Inc Transaction History

Poehling Capital Management, Inc.

$390 Million
Q3 2024

A detailed history of Poehling Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 963 shares of AMGN stock, worth $253,634. This represents 0.08% of its overall portfolio holdings.

Number of Shares

963

Previous 977 1.43%

Holding current value

$253,634

Previous $305,000 1.64%

% of portfolio

0.08%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $4,331 - $4,723	-14 Reduced 1.43%	963 $310,000
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $2,688 - $3,245	10 Added 1.03%	977 $277,000
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1,789 - $2,019	7 Added 0.73%	967 $278,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $2.46 Million - $3.05 Million	-11,231 Reduced 92.13%	960 $258,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $42,639 - $50,420	199 Added 1.66%	12,191 $2.71 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $2.39 Million - $2.91 Million	10,564 Added 739.78%	11,992 $2.9 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $3.03 Million - $3.84 Million	-13,208 Reduced 90.24%	1,428 $375,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $64,420 - $72,654	-287 Reduced 1.92%	14,636 $3.3 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $212,483 - $236,457	-921 Reduced 5.81%	14,923 $3.63 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $21,269 - $23,529	-97 Reduced 0.61%	15,844 $3.83 Million
Q4 2021 Jan 10, 2022	BUY	$198.88 - $227.6 $950,447 - $1.09 Million	4,779 Added 42.81%	15,941 $3.59 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $260,030 - $304,657	1,225 Added 12.33%	11,162 $2.37 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $92,964 - $103,137	398 Added 4.17%	9,937 $2.42 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $121,828 - $141,971	-549 Reduced 5.44%	9,539 $2.37 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1.3 Million - $1.55 Million	6,021 Added 148.05%	10,088 $2.32 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $379,194 - $421,695	-1,616 Reduced 28.44%	4,067 $1.03 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $31,056 - $38,110	-157 Reduced 2.69%	5,683 $1.34 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $1.06 Million - $1.41 Million	5,840 New	5,840 $1.18 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $100,056 - $112,800	-540 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $16,605 - $18,651	-100 Reduced 15.63%	540 $100,000
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $15,248 - $17,820	90 Added 16.36%	640 $109,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $92,834 - $103,724	550	550 $96,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Poehling Capital Management, Inc. with notifications on news.

Account

Poehling Capital Management, Inc. Amgen Inc Transaction History